ADVM Insider Holders & Insider Ownership - Adverum Biotechnologies Inc.

List of insiders holdings for Adverum Biotechnologies Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
Leonard Braden Michael 10% Owner	2025-03-27 19:06:28	141,800 2,722,761	2,864,561	Form 4
Zygtech LLC 10% Owner	2015-04-15 17:25:58	2,438,176 0	2,438,176	Form 4
Venrock Associates VI L.P. Venrock Partners VI L.P. Venrock Management VI LLC Venrock Partners Management VI LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC VHCP Management LLC Hove Anders D Koh Bong Y 10% Owner	2014-08-07 15:17:11	0 2,365,471	2,365,471	Form 4
Venrock Associates VI L.P. Venrock Partners VI L.P. Venrock Management VI LLC Venrock Partners Management VI LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC VHCP Management LLC ROBERTS BRYAN E Hove Anders D 10% Owner	2014-07-30 16:29:46	0 1,965,471	1,965,471	Form 3
REGENERON PHARMACEUTICALS INC 10% Owner	2022-02-11 16:07:29	1,809,098 0	1,809,098	Form 13G
Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC 10% Owner	2015-02-13 16:41:38	1,382,735 0	1,382,735	Form 13G
Chalberg Thomas W. Chief Executive Officer	2015-06-11 18:21:39	258,988 840,413	1,099,401	Form 4
Russo Carlo EVP and Chief Medical Officer	2016-05-13 17:48:19	781,991 0	781,991	Form 4
Blumenkranz Mark S. Director	2016-02-17 17:37:21	543,227 31,593	574,820	Form 4
Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant IV Luxco S.a r.l. Versant Capital IV (Switzerland) GmbH 10% Owner	2024-05-14 17:06:37	500,387 0	500,387	Form 13D
Salzman Amber President and CEO	2018-02-20 19:15:32	478,000 0	478,000	Form 4
Schwartz Steven Daniel Director	2017-06-14 19:07:11	432,593 0	432,593	Form 4
DeRespino Christopher See Remarks	2021-06-29 18:53:32	425,000 0	425,000	Form 3
Thedinga Angela Chief Technology Officer	2021-08-10 21:25:16	270,000 0	270,000	Form 4
Barone Samuel B. SVP, Clinical Development	2017-02-13 17:35:56	256,335 0	256,335	Form 4
Fischer Laurent CEO, PRESIDENT AND DIRECTOR	2025-02-27 16:05:11	246,614 0	246,614	Form 4
Rubio Roman G. SVP, Translational Medicine	2016-02-17 17:31:11	240,650 0	240,650	Form 4
PATTERSON LEONE D President and CFO	2021-02-18 21:03:54	240,000 0	240,000	Form 4
Beckman Richard Chief Medical Officer	2023-03-03 17:23:14	225,000 0	225,000	Form 4
GUERIN JOHN PATRICK Director 10% Owner	2015-06-11 21:09:04	0 200,000	200,000	Form 4
Clark Julie Chief Medical Officer	2021-10-04 17:36:15	164,723 0	164,723	Form 4
Braun Shirley VP, Human Resources	2016-02-17 17:26:09	161,140 0	161,140	Form 4
Countouriotis Athena SVP, Chief Medical Officer	2018-02-20 19:16:22	160,000 0	160,000	Form 4
Osborne Aaron Chief Medical Officer	2021-02-18 21:04:39	150,000 0	150,000	Form 4
Hull Hans Chief Executive Officer	2015-08-25 17:09:21	137,210 0	137,210	Form 4
Soparkar Peter CHIEF OPERATING OFFICER	2025-02-27 16:05:15	120,864 0	120,864	Form 4
Leung Thomas Chief Financial Officer	2020-02-21 19:17:15	120,000 0	120,000	Form 4
Rakow John SVP, Genl Counsel, Acting CFO	2022-09-16 19:00:02	118,070 0	118,070	Form 4
Riley Brigit Chief Scientific Officer	2023-03-17 18:02:59	117,435 0	117,435	Form 4
Swartzburg Michael Principal Accounting Officer	2016-02-17 17:28:24	82,113 0	82,113	Form 4
Cheng Jennifer C. General Counsel	2019-02-19 16:17:54	80,000 0	80,000	Form 4
Wachter Paul Director	2016-03-02 17:12:24	31,951 37,161	69,112	Form 4
Rubinstein Linda M CHIEF FINANCIAL OFFICER	2025-02-27 16:05:10	68,075 0	68,075	Form 4
Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER	2025-02-27 16:05:12	63,442 0	63,442	Form 4
Ozden Rabia Gurses Chief Medical Officer	2025-02-27 16:05:13	56,875 0	56,875	Form 4
MCLAUGHLIN JOHN PETER Director	2016-02-17 17:42:42	22,238 26,560	48,798	Form 4
Spivey Richard N. Director	2019-08-02 16:26:55	45,000 0	45,000	Form 4
Bain Linda Chief Financial Officer	2015-08-25 17:00:49	41,930 0	41,930	Form 4
Gasmi Mehdi Director	2021-05-14 20:01:59	40,000 0	40,000	Form 4
Woiwode Thomas Director	2021-05-14 20:05:38	40,000 0	40,000	Form 4
Cleveland Paul B Director	2018-06-15 16:25:24	35,000 0	35,000	Form 4
Carter Eric G Director	2020-06-25 17:44:15	30,000 0	30,000	Form 4
Hemrajani Rekha Director	2020-06-25 17:45:04	30,000 0	30,000	Form 4
Kiss Szilard Director	2024-06-20 16:43:07	21,040 0	21,040	Form 4
D'Souza Rupert Chief Financial Officer	2022-05-17 18:28:44	20,850 0	20,850	Form 4
Machado Patrick Director	2024-06-20 16:43:59	13,820 0	13,820	Form 4
Lupher Jr. Mark L. Director	2024-06-20 16:48:15	10,520 0	10,520	Form 4
Nicholson C. David Director	2024-06-20 16:49:31	10,520 0	10,520	Form 4
Hong Soo Director	2024-06-20 16:48:45	10,520 0	10,520	Form 4
Svoronos Dawn Director	2024-06-20 16:47:26	10,520 0	10,520	Form 4
Tuckson Reed Vaughn Director	2024-06-20 16:46:36	10,520 0	10,520	Form 4
Whitcup Scott M Director	2024-06-20 16:45:42	10,520 0	10,520	Form 4
Scopa James Paul Director	2024-06-20 16:44:59	10,520 0	10,520	Form 4
PECOTA NANCY E Principal Accounting Officer	2022-06-07 19:11:36	0 0	0	Form 3
Finer Mitchell H. Former Director Director	2019-10-25 16:05:56	0 0	0	Form 4/A
THRIFT JACK ANTHONY Interim CFO	2021-09-13 17:49:31	0 0	0	Form 3
Flynn James E Deerfield Mgmt L.P. Deerfield Special Situations Fund L.P. Deerfield Special Situations International Master Fund L.P. Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT CO Deerfield Private Design Fund III L.P. DEERFIELD PARTNERS LP Deerfield International Master Fund L.P. Possible Members of 10% Group 10% Owner	2016-02-16 08:25:36	0 0	0	Form 13G

Insider Holders & Insider Ownership - Adverum Biotechnologies Inc. (ADVM)